Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Collin M. Todd currently holds 93,904 shares of Odyssey Therapeutics, Inc. (ODTX), valued at approximately $0. This represents their equity stake as See Remarks.
Based on SEC Form 4 filings, Collin M. Todd has been a net neutral trader of ODTX stock. They have purchased $0 and sold $0 worth of shares.
Collin M. Todd's most recent insider trade was on May 7, 2026, when they sold 93,904 shares at $0.00 per share.
Collin M. Todd serves as See Remarks at Odyssey Therapeutics, Inc. (ODTX). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Collin M. Todd holds the position of See Remarks at Odyssey Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Collin M. Todd has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Collin M. Todd was on May 7, 2026, when they purchased $0 worth of ODTX shares. This transaction involved 93,904 shares at N/A per share.
Collin M. Todd currently owns 93,904 shares of Odyssey Therapeutics, Inc. (ODTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Collin M. Todd's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Collin M. Todd has 1 Form 4 filings on record as an insider at Odyssey Therapeutics, Inc..
Set alerts for Collin M. Todd and 40,000+ other insiders.